| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/01/2011 | CN102078295A Productive technology of docetaxel injection |
| 06/01/2011 | CN102078293A Taxol solution preparation coordinated with fat emulsion for injection |
| 06/01/2011 | CN102078292A Collagen oral liquid with improved bioavailability |
| 06/01/2011 | CN102078289A Cream for promoting tissue regeneration and astringing wound and preparation method thereof |
| 06/01/2011 | CN102078288A Pediatric anesthesia induction oral administration formulation and preparation method thereof |
| 06/01/2011 | CN102078287A Ophthalmic gel of artificial musk and preparation method thereof |
| 06/01/2011 | CN102078286A In-situ gel containing ciclesonide for noses |
| 06/01/2011 | CN102078285A Nasal in-situ gel containing corticosteroids and H1 receptor antagonists |
| 06/01/2011 | CN102078284A Gatifloxacin-containing gel for eyes and preparation method thereof |
| 06/01/2011 | CN102077948A Effervescent tablet containing fructose sodium diphosphate |
| 06/01/2011 | CN102077828A Compound disinfectant containing quaternary ammonium salt |
| 06/01/2011 | CN101721376B Calcitonin sustained release microsphere composition and preparation method thereof |
| 06/01/2011 | CN101669905B Thymosin alpha1 injection-type subcutaneous implant |
| 06/01/2011 | CN101647780B Core-shell type magnetic nano-composite particle based on Fe3O4 and houghite and preparation method thereof |
| 06/01/2011 | CN101601659B Glutathione enteric-coated pellet and preparation method thereof |
| 06/01/2011 | CN101590028B Tulobuterol-containing aquogel patch and preparation method thereof |
| 06/01/2011 | CN101574343B Medicament composition for treating diabetes |
| 06/01/2011 | CN101559100B Acesodyne capsule for heart and stomach |
| 06/01/2011 | CN101536983B Albendazole oxide hydrochloride premix for animals |
| 06/01/2011 | CN101495150B Pharmaceutical composition improved in absorption of pharmacologically active substance |
| 06/01/2011 | CN101454003B Oral composition comprising 3-[5-[4-(cyclopentyloxy) -2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6- yl)methoxy]phenyl]propionic acid or salt thereof |
| 06/01/2011 | CN101450087B Adonis amurensis total-flavone mouth plaster |
| 06/01/2011 | CN101444555B Purely Chinese traditional medical film for curing oral ulcer and method for preparing same |
| 06/01/2011 | CN101396370B Medicine composition for treating mouth, throat disease and preparation method thereof |
| 06/01/2011 | CN101353379B Protein modified biological-inorganic nano composite material and preparation thereof |
| 06/01/2011 | CN101234095B Timely released preparation and preparation thereof |
| 06/01/2011 | CN101219140B Benzydamine Hcl soluble tablet and method for preparing the same |
| 06/01/2011 | CN101129341B Intra-oral disintegration compositions and process for producing same |
| 06/01/2011 | CN101062021B Diarrhea treating medical composition |
| 05/31/2011 | US7953788 System and method for queuing data for an application server |
| 05/31/2011 | US7951921 Multivalent carriers of bi-specific antibodies |
| 05/31/2011 | US7951904 Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor |
| 05/31/2011 | US7951898 Biodegradable polyketal polymers and methods for their formation and use |
| 05/31/2011 | US7951846 pH-sensitive polymeric micelles for drug delivery |
| 05/31/2011 | US7951840 Zinc salt compositions for the prevention of dermal and mucosal irritation |
| 05/31/2011 | US7951772 Tumor-activated prodrug compounds and treatment |
| 05/31/2011 | US7951614 Methods and compositions for the production of monoclonal antibodies |
| 05/31/2011 | US7951613 Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion |
| 05/31/2011 | US7951546 Compositions and methods for the diagnosis and treatment of tumor |
| 05/31/2011 | US7951530 Cyclic maltosylmaltose, cyclic maltosymaltose-forming enzyme, their preparation and uses |
| 05/31/2011 | US7951453 hydrophilic interior core containing metal or semiconductor and and hydrophobic ligand encapsulated micelle |
| 05/31/2011 | US7951404 Concentrate for preparing a disinfectant and methods for its preparation and use |
| 05/31/2011 | US7951401 Stabilised solid drug dispersions in an organic carrier and a process for preparing the same |
| 05/31/2011 | US7951398 Pharmaceutical preparation comprising an active dispersed on a matrix |
| 05/31/2011 | US7951397 Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient |
| 05/31/2011 | US7951395 Rapid release, water permeable self adhesive polymer matrix system; photodynamic therapy and/or diagnosis of skin lesions |
| 05/31/2011 | US7951387 Comprising polyhexamethylene biguanide (PHMB), 1,2-hexanediol, 1,2-octanediol in pH stabilizing surfactant solution; nonirritating antimicrobial action; premoistened fabric pads |
| 05/31/2011 | US7951379 Hollow nanoparticle of NBsAg large protein for drug delivery |
| 05/31/2011 | US7951378 Modified cell adhesion molecule comprising immunoglobulin heavy chain fusion for treatment and prevention of respiratory system disorders |
| 05/31/2011 | US7951375 Methods of inducing an immune response |
| 05/31/2011 | US7951356 Tissue factor compositions and kits for coagulation and tumor treatment |
| 05/31/2011 | CA2600762C Stable organic peroxide compositions |
| 05/31/2011 | CA2492739C Process for preparing a sterile high molecular weight hyaluronic acid formulation |
| 05/31/2011 | CA2491312C Bioerodible film for ophthalmic drug delivery |
| 05/31/2011 | CA2441357C Agent for the prevention and treatment of sexually transmitted diseases-i |
| 05/31/2011 | CA2440012C Highly flexible transdermal therapeutic system having nicotine as active substance |
| 05/31/2011 | CA2438108C Improved drug formulation of soluble glass particles suspended in a liquid |
| 05/31/2011 | CA2428993C Solvent systems for pharmaceutical agents |
| 05/31/2011 | CA2416566C Depot formulation comprising ceftiofur and peroxidized natural oil |
| 05/31/2011 | CA2412501C Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury |
| 05/31/2011 | CA2350054C Improved fast disintegrating tablet |
| 05/31/2011 | CA2319080C Multivalent antibacterial agents |
| 05/27/2011 | CA2723119A1 Pharmaceutical compound comprising a strontium salt, vitamin d and a cyclodextrin |
| 05/26/2011 | WO2011063336A2 Secondary site of antigen stimulation for therapeutic vaccination |
| 05/26/2011 | WO2011063275A1 Suppression of cancer metastasis |
| 05/26/2011 | WO2011063264A1 Methods and compositions related to immunogenic fibrils |
| 05/26/2011 | WO2011063178A2 Intravenous infusion of curcumin and a calcium channel blocker |
| 05/26/2011 | WO2011063164A2 Sustained release cannabinoid medicaments |
| 05/26/2011 | WO2011063160A1 Methods for improving oral delivery |
| 05/26/2011 | WO2011063158A1 Salt form of a multi-arm polymer-drug conjugate |
| 05/26/2011 | WO2011063156A2 Acid salt forms of polymer-drug conjugates and alkoxylation methods |
| 05/26/2011 | WO2011062965A2 Targeting monomers and polymers having targeting blocks |
| 05/26/2011 | WO2011062936A2 Self-assembled toroidal-spiral particles and manufacture and uses thereof |
| 05/26/2011 | WO2011062420A2 Nanoparticles for tumor-targeting and processes for the preparation thereof |
| 05/26/2011 | WO2011062244A1 Carrier, method for producing same, and applications of same |
| 05/26/2011 | WO2011062217A1 Magnetic iron oxide microparticle powder, aqueous dispersion containing magnetic particles, and process for production of same |
| 05/26/2011 | WO2011062132A1 Process for production of w/o/w emulsion, process for production of liposome employing the process, and porous membrane for use in the methods |
| 05/26/2011 | WO2011061995A1 Process for production of purified egg-yolk phospholipid composition, and pharmaceutical composition, cosmetic composition or food composition comprising purified egg-yolk phospholipid composition produced by the process |
| 05/26/2011 | WO2011061747A1 Antifungal and anti parasitic conjugates of amphotericin b derivatives |
| 05/26/2011 | WO2011061712A1 Formulations of antibody |
| 05/26/2011 | WO2011061615A1 Polysaccharide / bmp complexes which are soluble at physiological ph |
| 05/26/2011 | WO2011061298A1 Use of prostaglandins f2alpha and analogues for the healing of corneal and conjunctival lesions |
| 05/26/2011 | WO2011061297A1 Method for treating retinal conditions using an intraocular tamponade |
| 05/26/2011 | WO2011061155A1 Antifungal formulations and their use |
| 05/26/2011 | WO2011060922A1 Formulation for hgh and rhigf-1 combination |
| 05/26/2011 | WO2011041609A3 Topical formulations |
| 05/26/2011 | WO2011041300A4 Reduced-odor polyol composition and method of producing same |
| 05/26/2011 | WO2011039444A3 Composition, use, and preservation method |
| 05/26/2011 | WO2011039180A3 Novel vaccine composition against influenza |
| 05/26/2011 | WO2011036677A3 Sustained release composition of ranolazine |
| 05/26/2011 | WO2011036521A3 Formulations comprising triptan compounds |
| 05/26/2011 | WO2011036191A3 Gold –coated magnetic glyconanoparticles functionalised with proteins for use as diagnostic and therapeutic agents |
| 05/26/2011 | WO2010148253A3 Formulations for lysosomal enzymes |
| 05/26/2011 | WO2010119387A3 A medicinal cream made using miconazole nitrate, fluticasone propionate, and chitosan, and a process to make the same |
| 05/26/2011 | WO2010119386A3 A medicinal cream made using clotrimazole, fluticasone propionate, and chitosan, and a process to make the same |
| 05/26/2011 | WO2010119368A3 A medicinal cream made using miconazole nitrate and chitosan, and a process to make the same |
| 05/26/2011 | WO2010119366A3 A medicinal cream made using fluticasone propionate, and chitosan, and a process to make the same |
| 05/26/2011 | WO2010109425A3 A medicinal steroids cream and a process to make it |
| 05/26/2011 | WO2010105842A3 Preparation for external application |
| 05/26/2011 | WO2010103022A3 Oil-in-water adjuvanted influenza vaccine |